Endocare's keyhole cardiac cryosurgery system:
This article was originally published in Clinica
Executive Summary
Endocare has received US FDA 510(k) marketing clearance to use its Cryocare surgical system during a minimally invasive cardiac cryosurgery procedure for treating arrhythmia. The thoracoscopic surgery clearance broadens the applicability of cryosurgery as an ablation tool and strengthens the company's ability to specifically market the technology to treat cardiac arrhythmia to a larger group of patients, says the Irvine, California firm.